Harvard Bioscience (HBIO) Capital Expenditures Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.05 Bn | 120.83 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.78 Bn | 43.96 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 32.95 Bn | 31.30 Bn | 1.53 Bn | - |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.02 Bn | 13.45 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.77 Bn | 13.64 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn | 21.73% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | -16.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.96% |
| Dec 31, 2025 | 49.17% |
| Sep 30, 2025 | -76.48% |
| Jun 30, 2025 | -89.12% |
| Mar 31, 2025 | -20.47% |
| Dec 31, 2024 | -63.73% |
| Sep 30, 2024 | 305.53% |
| Jun 30, 2024 | 58.22% |
| Mar 31, 2024 | 187.95% |
| Dec 31, 2023 | 253.19% |
| Sep 30, 2023 | -50.90% |
| Jun 30, 2023 | 16.97% |
| Mar 31, 2023 | -52.44% |
| Dec 31, 2022 | -34.36% |
| Sep 30, 2022 | -7.92% |
| Jun 30, 2022 | 114.56% |
| Mar 31, 2022 | 211.92% |
| Dec 31, 2021 | 459.38% |
| Sep 30, 2021 | -14.89% |
| Jun 30, 2021 | -27.21% |